Suparma | Income Statement
Fiscal year is January-December. All values IDR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,395,838
1,550,810
1,621,516
1,932,435
2,093,138
2,389,269
Cost of Goods Sold (COGS) incl. D&A
1,161,630
1,293,081
1,373,535
1,625,251
1,782,128
2,020,058
Gross Income
234,209
257,729
247,981
307,184
311,010
369,211
SG&A Expense
96,622
116,057
130,500
134,873
137,852
158,857
EBIT
137,586
-
117,481
156,370
173,158
208,477
Non Operating Income/Expense
116,298
9,023
79,878
31,644
2,875
46,385
Interest Expense
53,414
67,705
95,985
79,798
55,861
54,496
Pretax Income
31,506
65,779
56,816
111,358
121,309
109,673
Income Tax
7,649
16,818
14,219
30,295
29,029
27,441
Consolidated Net Income
23,857
48,961
42,597
81,063
92,280
82,233
Net Income
23,857
48,961
42,597
81,063
92,280
82,233
Net Income After Extraordinaries
23,857
48,961
42,597
81,063
92,280
82,233
Net Income Available to Common
23,857
48,961
42,597
81,063
92,280
82,233
EPS (Basic)
16.00
33.00
29.00
53.00
44.00
38.89
Basic Shares Outstanding
1,492
1,492
1,492
1,519
2,115
2,115
EPS (Diluted)
15.99
32.81
28.55
53.35
43.64
38.89
Diluted Shares Outstanding
1,492
1,492
1,492
1,519
2,115
2,115
EBITDA
215,743
223,464
206,450
245,264
260,176
295,858
Other Operating Expense
-
-
-
15,941
-
1,876
Non-Operating Interest Income
619
835
1,566
3,143
6,886
2,077
About Suparma
View Profile
